Hyderabad: BioAsia, Asia's largest annual global biotechnology and life sciences forum, announced that the prestigious Genome ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

BioAstra, a pioneering force in space medicine and biotechnology, is set to revolutionize human health with the launch of Twin Astra-a first-of-its-kind deep-space research initiative poised to ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. The ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will ...

Looking ahead, Oncimmune forecasts financial 2025 revenue to grow 33% to around GBP4 million. The company expects to reach break-even by financial 2026, driven by its ImmunoINSIGHTS platform and ...

Biovet, a subsidiary of the Bharat Biotech Group, has received approval from the CDSCO for its innovative LSD vaccine, ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Few companies in the biotech industry have performed better in the past two years than Summit Therapeutics (NASDAQ: SMMT).

President Trump’s tariffs in China are in place and hitting all products imported from the country — including a number of pharmaceutical drugs that Americans rely upon. Chinese imports ...

Amgen's dividend yield remains attractive, with a moderate payout ratio and strong free cash flow. Click here to see why AMGN ...